Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1518

Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
In 2018, the global Metastatic Colorectal Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metastatic Colorectal Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metastatic Colorectal Cancer Treatment development in United States, Europe and China.

The key players covered in this study
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals

Market segment by Type, the product can be split into
Surgery
Chemotherapy

Market segment by Application, split into
Hospitals
Clinics
Cancer Research Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metastatic Colorectal Cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Metastatic Colorectal Cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metastatic Colorectal Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Chemotherapy
1.5 Market by Application
1.5.1 Global Metastatic Colorectal Cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metastatic Colorectal Cancer Treatment Market Size
2.2 Metastatic Colorectal Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Colorectal Cancer Treatment Market Size by Regions (2014-2025)
2.2.2 Metastatic Colorectal Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Metastatic Colorectal Cancer Treatment Market Size by Manufacturers
3.1.1 Global Metastatic Colorectal Cancer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Metastatic Colorectal Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Metastatic Colorectal Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Metastatic Colorectal Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metastatic Colorectal Cancer Treatment Market Size by Type (2014-2019)
4.2 Global Metastatic Colorectal Cancer Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Metastatic Colorectal Cancer Treatment Market Size (2014-2019)
5.2 Metastatic Colorectal Cancer Treatment Key Players in United States
5.3 United States Metastatic Colorectal Cancer Treatment Market Size by Type
5.4 United States Metastatic Colorectal Cancer Treatment Market Size by Application

6 Europe
6.1 Europe Metastatic Colorectal Cancer Treatment Market Size (2014-2019)
6.2 Metastatic Colorectal Cancer Treatment Key Players in Europe
6.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Type
6.4 Europe Metastatic Colorectal Cancer Treatment Market Size by Application

7 China
7.1 China Metastatic Colorectal Cancer Treatment Market Size (2014-2019)
7.2 Metastatic Colorectal Cancer Treatment Key Players in China
7.3 China Metastatic Colorectal Cancer Treatment Market Size by Type
7.4 China Metastatic Colorectal Cancer Treatment Market Size by Application

8 Japan
8.1 Japan Metastatic Colorectal Cancer Treatment Market Size (2014-2019)
8.2 Metastatic Colorectal Cancer Treatment Key Players in Japan
8.3 Japan Metastatic Colorectal Cancer Treatment Market Size by Type
8.4 Japan Metastatic Colorectal Cancer Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metastatic Colorectal Cancer Treatment Market Size (2014-2019)
9.2 Metastatic Colorectal Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Metastatic Colorectal Cancer Treatment Market Size by Type
9.4 Southeast Asia Metastatic Colorectal Cancer Treatment Market Size by Application

10 India
10.1 India Metastatic Colorectal Cancer Treatment Market Size (2014-2019)
10.2 Metastatic Colorectal Cancer Treatment Key Players in India
10.3 India Metastatic Colorectal Cancer Treatment Market Size by Type
10.4 India Metastatic Colorectal Cancer Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Metastatic Colorectal Cancer Treatment Market Size (2014-2019)
11.2 Metastatic Colorectal Cancer Treatment Key Players in Central & South America
11.3 Central & South America Metastatic Colorectal Cancer Treatment Market Size by Type
11.4 Central & South America Metastatic Colorectal Cancer Treatment Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metastatic Colorectal Cancer Treatment Introduction
12.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metastatic Colorectal Cancer Treatment Introduction
12.2.4 Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metastatic Colorectal Cancer Treatment Introduction
12.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metastatic Colorectal Cancer Treatment Introduction
12.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metastatic Colorectal Cancer Treatment Introduction
12.5.4 Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metastatic Colorectal Cancer Treatment Introduction
12.6.4 Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Taiho Oncology
12.7.1 Taiho Oncology Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metastatic Colorectal Cancer Treatment Introduction
12.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.7.5 Taiho Oncology Recent Development
12.8 Genentech
12.8.1 Genentech Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metastatic Colorectal Cancer Treatment Introduction
12.8.4 Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.8.5 Genentech Recent Development
12.9 EMD Serono
12.9.1 EMD Serono Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metastatic Colorectal Cancer Treatment Introduction
12.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.9.5 EMD Serono Recent Development
12.10 Suzhou Zelgen Biopharmaceuticals
12.10.1 Suzhou Zelgen Biopharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metastatic Colorectal Cancer Treatment Introduction
12.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2014-2019)
12.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details